PriceTargets.com logo

Astera Labs - ALAB Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $187.06
  • Forecasted Upside: 22.65%
  • Number of Analysts: 24
  • Breakdown:
  • 0 Sell Ratings
  • 8 Hold Ratings
  • 15 Buy Ratings
  • 1 Strong Buy Ratings
$152.51 As of 12/4/2025 05:00 PM ET
▲ +0.01 (0.01%)

This chart shows the closing price for ALAB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Astera Labs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALAB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALAB

Analyst Price Target is $187.06
▲ +22.65% Upside Potential
This price target is based on 24 analysts offering 12 month price targets for Astera Labs in the last 3 months. The average price target is $187.06, with a high forecast of $275.00 and a low forecast of $82.00. The average price target represents a 22.65% upside from the last price of $152.51.

This chart shows the closing price for ALAB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 24 polled investment analysts is to moderate buy stock in Astera Labs. This rating has held steady since July 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 1 strong buy ratings
  • 11 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 1 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 14 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 15 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 15 buy ratings
  • 8 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/3/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight$210.00
12/3/2025Jefferies Financial GroupReiterated RatingBuy ➝ Buy
11/21/2025Raymond James FinancialInitiated CoverageHold
11/20/2025BNP ParibasInitiated CoverageOutperform
11/20/2025BNP Paribas ExaneInitiated CoverageOutperform$225.00
11/17/2025Northland SecuritiesSet Target$175.00
11/17/2025Northland CapmkUpgradeHold ➝ Strong-Buy
11/17/2025Northland SecuritiesUpgradeMarket Perform ➝ Outperform$175.00
11/5/2025CowenReiterated RatingHold ➝ Hold
11/5/2025Needham & Company LLCBoost TargetBuy ➝ Buy$205.00 ➝ $220.00
11/5/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$200.00 ➝ $210.00
11/5/2025Roth CapitalBoost TargetBuy ➝ Buy$200.00 ➝ $225.00
11/5/2025JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$180.00 ➝ $215.00
11/5/2025Stifel NicolausBoost TargetBuy ➝ Buy$185.00 ➝ $200.00
11/5/2025TD CowenLower TargetHold ➝ Hold$225.00 ➝ $170.00
10/20/2025BarclaysReiterated RatingOverweight ➝ Equal Weight$155.00
10/17/2025Stifel NicolausBoost TargetBuy ➝ Buy$174.00 ➝ $185.00
10/8/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
10/6/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
10/3/2025Bank of AmericaInitiated CoverageNeutral$230.00
10/1/2025TD CowenInitiated CoverageHold$200.00
9/30/2025CowenInitiated CoverageHold
9/27/2025Weiss RatingsReiterated RatingHold (C-) ➝ Hold (C-)
9/17/2025CitigroupBoost TargetBuy ➝ Buy$160.00 ➝ $275.00
9/2/2025Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$160.00 ➝ $200.00
8/29/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$155.00 ➝ $200.00
8/29/2025CICC ResearchInitiated CoverageOutperform$190.00
8/12/2025Zacks ResearchUpgradeStrong-Buy
8/7/2025BarclaysReiterated RatingOverweight ➝ Overweight$75.00 ➝ $155.00
8/7/2025SusquehannaBoost TargetNeutral ➝ Neutral$80.00 ➝ $125.00
8/6/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$125.00 ➝ $155.00
8/6/2025Evercore ISIBoost TargetOutperform ➝ Outperform$104.00 ➝ $215.00
8/6/2025Needham & Company LLCBoost TargetBuy ➝ Buy$100.00 ➝ $170.00
8/4/2025Stifel NicolausSet TargetBuy ➝ Buy$110.00 ➝ $145.00
7/30/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$99.00 ➝ $125.00
7/22/2025Northland CapmkDowngradeStrong-Buy ➝ Hold
7/22/2025Jefferies Financial GroupBoost TargetBuy ➝ Buy$95.00 ➝ $130.00
7/22/2025Northland SecuritiesDowngradeOutperform ➝ Market Perform$120.00
7/18/2025Stifel NicolausBoost TargetBuy ➝ Buy$100.00 ➝ $110.00
5/22/2025William BlairInitiated CoverageOutperform
5/21/2025Evercore ISIBoost TargetOutperform ➝ Outperform$87.00 ➝ $104.00
5/16/2025SusquehannaInitiated CoverageNeutral$80.00
5/12/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$99.00 ➝ $99.00
5/7/2025Roth CapitalSet TargetBuy ➝ Buy$100.00
5/7/2025Needham & Company LLCLower TargetBuy ➝ Buy$140.00 ➝ $100.00
5/7/2025BarclaysBoost TargetOverweight ➝ Overweight$70.00 ➝ $75.00
4/17/2025Stifel NicolausLower TargetBuy ➝ Buy$150.00 ➝ $100.00
4/14/2025CitigroupLower TargetBuy ➝ Buy$120.00 ➝ $100.00
3/14/2025Raymond James FinancialInitiated CoverageOutperform$82.00
2/11/2025Craig HallumBoost TargetBuy ➝ Buy$105.00 ➝ $125.00
2/11/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$140.00 ➝ $140.00
1/28/2025Northland CapmkUpgradeHold ➝ Strong-Buy
1/28/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$142.00 ➝ $114.00
1/28/2025Northland SecuritiesUpgradeMarket Perform ➝ Outperform$120.00 ➝ $120.00
1/21/2025Morgan StanleyDowngradeOverweight ➝ Equal Weight$142.00 ➝ $142.00
1/17/2025BarclaysBoost TargetOverweight ➝ Overweight$87.00 ➝ $135.00
1/6/2025Stifel NicolausBoost TargetBuy ➝ Buy$100.00 ➝ $150.00
1/2/2025Northland CapmkDowngradeStrong-Buy ➝ Hold
1/2/2025Northland SecuritiesDowngradeOutperform ➝ Market Perform$100.00 ➝ $120.00
12/20/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$94.00 ➝ $142.00
11/18/2024CitigroupInitiated CoverageBuy$120.00
11/5/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$74.00 ➝ $94.00
11/5/2024Roth MkmBoost TargetBuy ➝ Buy$80.00 ➝ $105.00
11/5/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$70.00 ➝ $110.00
11/5/2024Stifel NicolausBoost TargetBuy ➝ Buy$80.00 ➝ $100.00
11/5/2024BarclaysBoost TargetOverweight ➝ Overweight$70.00 ➝ $87.00
11/5/2024Craig HallumBoost TargetBuy ➝ Buy$75.00 ➝ $105.00
11/5/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$60.00 ➝ $100.00
10/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$65.00 ➝ $65.00
10/9/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$55.00 ➝ $74.00
9/4/2024Morgan StanleyUpgradeEqual Weight ➝ Overweight$55.00 ➝ $55.00
8/7/2024Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$85.00 ➝ $60.00
8/7/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$95.00 ➝ $70.00
8/7/2024Craig HallumLower TargetBuy ➝ Buy$90.00 ➝ $75.00
8/7/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$85.00 ➝ $55.00
8/7/2024BarclaysLower TargetOverweight ➝ Overweight$85.00 ➝ $70.00
8/7/2024Roth MkmLower TargetBuy ➝ Buy$85.00 ➝ $60.00
8/7/2024Needham & Company LLCLower TargetBuy ➝ Buy$85.00 ➝ $65.00
8/7/2024Evercore ISILower TargetOutperform ➝ Outperform$98.00 ➝ $80.00
8/5/2024Stifel NicolausLower TargetBuy ➝ Buy$87.00 ➝ $80.00
5/8/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$85.00
4/16/2024Evercore ISIInitiated CoverageOutperform$100.00
4/15/2024Craig HallumInitiated CoverageBuy$90.00
4/15/2024Jefferies Financial GroupInitiated CoverageBuy$85.00
4/15/2024Deutsche Bank AktiengesellschaftInitiated CoverageBuy$85.00
4/15/2024Morgan StanleyInitiated CoverageOverweight$81.00
4/15/2024JPMorgan Chase & Co.Initiated CoverageOverweight$85.00
4/15/2024BarclaysInitiated CoverageOverweight$85.00
4/15/2024Needham & Company LLCInitiated CoverageBuy$85.00
4/15/2024Stifel NicolausInitiated CoverageBuy$81.00
4/15/2024Roth MkmInitiated CoverageBuy$85.00
3/25/2024Northland SecuritiesInitiated CoverageOutperform$85.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.19 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 68 very positive mentions
  • 34 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 57 very positive mentions
  • 43 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
Mentions as of
10/5/2025
  • 58 very positive mentions
  • 35 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 101 very positive mentions
  • 33 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 101 very positive mentions
  • 33 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Astera Labs logo
Astera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.
Read More

Today's Range

Now: $152.51
Low: $147.00
High: $154.00

50 Day Range

MA: $170.75
Low: $139.29
High: $225.43

52 Week Range

Now: $152.51
Low: $47.13
High: $262.90

Volume

3,802,758 shs

Average Volume

6,496,565 shs

Market Capitalization

$25.76 billion

P/E Ratio

137.40

Dividend Yield

N/A

Beta

1.51

Frequently Asked Questions

What sell-side analysts currently cover shares of Astera Labs?

The following Wall Street sell-side analysts have issued research reports on Astera Labs in the last year: Bank of America Corporation, Barclays PLC, BNP Paribas, BNP Paribas Exane, CICC Research, Citigroup Inc., Cowen Inc, Craig Hallum, Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Capmk, Northland Securities, Raymond James Financial, Inc., Roth Capital, Stifel Nicolaus, Susquehanna, TD Cowen, Wall Street Zen, Weiss Ratings, William Blair, and Zacks Research.
View the latest analyst ratings for ALAB.

What is the current price target for Astera Labs?

0 Wall Street analysts have set twelve-month price targets for Astera Labs in the last year. Their average twelve-month price target is $187.06, suggesting a possible upside of 22.7%. Citigroup Inc. has the highest price target set, predicting ALAB will reach $275.00 in the next twelve months. Raymond James Financial, Inc. has the lowest price target set, forecasting a price of $82.00 for Astera Labs in the next year.
View the latest price targets for ALAB.

What is the current consensus analyst rating for Astera Labs?

Astera Labs currently has 8 hold ratings, 15 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ALAB.

What other companies compete with Astera Labs?

Other companies that are similar to Astera Labs include Vertiv, L3Harris Technologies, NXP Semiconductors, Celestica and Ubiquiti. Learn More about companies similar to Astera Labs.

How do I contact Astera Labs' investor relations team?

Astera Labs' physical mailing address is 2901 Tasman Drive, Suite 205, Santa Clara, CA 95054, United States. The company's listed phone number is 408-242-7319 and its investor relations email address is [email protected]. The official website for Astera Labs is www.asteralabs.com. Learn More about contacing Astera Labs investor relations.